Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds

Cytometry B Clin Cytom. 2023 Nov;104(6):468-470. doi: 10.1002/cyto.b.22133. Epub 2023 May 24.

Muzhda Haem Rahimi^{1

2}, Filippo Conti², Jean-Francois Llitjos^{2

3

4}, Aurore Fleurie^{2

3}, Valérie Cerro⁴, Fabienne Venet^{1

5}, Anne-Claire Lukaszewicz^{2

4}, Guillaume Monneret^{1

2}

¹ Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon, France.
² Université de Lyon, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression", Claude Bernard University Lyon_1, Lyon, France.
³ Open Innovation and Partnerships (OI&P), bioMérieux S.A., Marcy l'Etoile, France.
⁴ Hospices Civils de Lyon, Anesthesiology and Critical Care Medicine, Hôpital E. Herriot, Lyon, France.
⁵ NLRP3 Inflammation and Immune Response to Sepsis Team, Centre International de Recherche in Infectiology (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Claude Bernard University Lyon 1, Lyon, France.

No abstract available

Publication types